Prof. Chris Griffiths University of Manchester, UK

1 Talk

Chris Griffiths qualified in Medicine from St Thomas’ Hospital Medical School, London University where he also gained a 1st Class Hons BSc in Anatomy. He trained in Dermatology at St Mary’s Hospital, London, and at the University of Michigan, USA, where he was on Faculty for 4 years. He was... read moreappointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an honorary consultant dermatologist at Salford Royal NHS Foundation Trust. Chris introduced a multidisciplinary clinic for severe psoriasis – the Manchester Psoriasis Service – awarded Hospital Doctor Dermatology Team of the Year in 2002. At the University of Manchester he has held several posts including: Faculty Research Dean; Head of Medicine and Neuroscience; Head of the School of Translational Medicine; and Director of the Manchester Academic Health Science Centre.

Professor Griffiths’ named lectureships include: Sydney Watson Smith (2006); Parkes Weber (2007); Von Zumbusch, Munich (2007) ; Hellerstrom, Stockholm (2010; and Eugene Farber (2015). He received the lifetime achievement award of the American Skin Association in 2009 and in 2015 the Sir Archibald Gray Medal for outstanding service to British Dermatology. In 2011 he was appointed as a National Institute of Health Research (NIHR) Senior Investigator and elected to Fellowship of the Academy of Medical Sciences.

Professor Griffiths is co-founder and current President of the International Psoriasis Council and a past-President of the British Association of Dermatologists, European Dermatology Forum and British Society for Investigative Dermatology. He is a Board member the European Society for Dermatological Research and the International League of Dermatological Societies. Chris has published 530 Pubmed cited articles in scientific journals with an H-Index of 96 (Google Scholar), and is senior editor of Rook’s Textbook of Dermatology. He has long-standing research interests in all aspects of psoriasis including: immunological mechanisms, immunotherapy, pharmacogenomics and the ‘brain–skin axis’.